Health experts across the United States say they’re hopeful we could see a safe and effective coronavirus vaccine early next year. That would slow the spread of the virus, potentially saving millions from becoming infected, and eventually allow the country to fully reopen. But even after a vaccine is approved, there won’t be enough for everyone for everyone who wants it immediately. Meharry Medical College in Nashville is one of the dozens of institutions enrolled in “Operation Warp Speed,” the administration’s initiative to deliver 300 million doses of a vaccine by January 2021. Soledad O’Brien speaks with immunologist Dr. James E. K. Hildreth, president and CEO of Meharry, about why we may need to adjust our expectations if we’re hoping to see a vaccine by the end of the year.


Related Videos